role of ganciclovir in the prevention of Post-transplant lymph proliferative disease in children underwent liver transplantatio
Phase 2
- Conditions
- Transplanted organ and tissue status.Liver transplant status
- Registration Number
- IRCT2013120215530N2
- Lead Sponsor
- Vice Chancellor for research,Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 203
Inclusion Criteria
age less than 18 years; performing a liver transplant
Exclusion criteria: transplant before July 88 and after March 90; die within the first week after transplantation due to postoperative complications
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevention of Post-transplant lymph proliferative disease. Timepoint: A month later. Method of measurement: examinations.
- Secondary Outcome Measures
Name Time Method